1. Home
  2. FBK vs WVE Comparison

FBK vs WVE Comparison

Compare FBK & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$55.02

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.18

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBK
WVE
Founded
1906
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
FBK
WVE
Price
$55.02
$7.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
16
Target Price
$62.75
$30.25
AVG Volume (30 Days)
283.7K
5.9M
Earning Date
04-13-2026
05-07-2026
Dividend Yield
1.49%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$43.54
N/A
Revenue Next Year
$7.86
$85.67
P/E Ratio
$23.04
N/A
Revenue Growth
N/A
149.43
52 Week Low
$39.47
$5.02
52 Week High
$62.37
$21.73

Technical Indicators

Market Signals
Indicator
FBK
WVE
Relative Strength Index (RSI) 59.01 30.12
Support Level $51.79 $6.66
Resistance Level $56.30 $8.29
Average True Range (ATR) 1.14 0.61
MACD 0.69 -0.08
Stochastic Oscillator 72.98 27.65

Price Performance

Historical Comparison
FBK
WVE

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: